Blood
Medicines for Myelodysplastic syndrome (MDS)
A group of conditions where the bone marrow does not make enough healthy blood cells — ranging from mild to serious, and sometimes progressing to leukaemia.
Education and reference only. This explains which medicines are used and why, in plain language — it deliberately contains no doses and is not a substitute for advice from your doctor or pharmacist. Always discuss your own treatment with a qualified clinician, and check the BNF and the product labelling for prescribing detail.
Quick answer
What is Myelodysplastic syndrome (MDS)?
Myelodysplastic syndromes (MDS) are a group of conditions in which the bone marrow — where blood cells are made — does not work properly and fails to produce enough healthy, mature blood cells. This can lead to low levels of red cells (causing anaemia and tiredness), white cells (increasing infection risk) and platelets (causing bruising and bleeding), alone or in combination.
- How it is treated: Treatment is tailored to the type, severity, symptoms and the person's health, and ranges from monitoring to more intensive therapy.
- Self-care: Attending regular blood monitoring, seeking prompt treatment for infections or bleeding, keeping up with recommended vaccinations, and supportive care for fatigue all help.
- When to seek help: See a GP about persistent tiredness, recurrent infections, or unexplained bruising or bleeding, so blood counts can be checked.
What it is
Myelodysplastic syndromes (MDS) are a group of conditions in which the bone marrow — where blood cells are made — does not work properly and fails to produce enough healthy, mature blood cells. This can lead to low levels of red cells (causing anaemia and tiredness), white cells (increasing infection risk) and platelets (causing bruising and bleeding), alone or in combination. MDS mostly affects older adults and its severity varies widely: some forms are mild and slowly progressive, while others are more serious and can develop into a type of leukaemia. It is usually found through blood tests showing abnormal or low blood counts, confirmed by examining a bone marrow sample. Understanding the specific type and risk guides treatment.
How it is treated
Treatment is tailored to the type, severity, symptoms and the person's health, and ranges from monitoring to more intensive therapy. Milder MDS may simply be monitored, with supportive care such as blood transfusions for anaemia, treatment to boost blood cell production, and prompt treatment of infections. Higher-risk MDS may be treated with medicines that improve blood counts or slow progression, and, in suitable people, a stem cell (bone marrow) transplant offers the potential for cure. Managing symptoms and complications — anaemia, infection and bleeding risk — is central throughout. Care is guided by a haematology (blood cancer) team, with the plan reviewed as the condition evolves.
For this condition, these medicines
Medicine classes used for Myelodysplastic syndrome (MDS)
Each links to a full, dose-free guide — what it is, how it works, who can and cannot use it, side effects, interactions and FAQs.
Beyond medication
Lifestyle and self-care
Attending regular blood monitoring, seeking prompt treatment for infections or bleeding, keeping up with recommended vaccinations, and supportive care for fatigue all help. General healthy living supports wellbeing through treatment.
When to get help
When to see a doctor
See a GP about persistent tiredness, recurrent infections, or unexplained bruising or bleeding, so blood counts can be checked. People with MDS should seek prompt care for signs of infection (such as fever) or significant bleeding.
Not sure how urgent it is? It is always OK to call NHS 111 for advice, day or night.
Answers
Myelodysplastic syndrome (MDS): frequently asked questions
Is myelodysplastic syndrome a cancer?
MDS is considered a type of blood cancer or a pre-cancerous bone marrow disorder. Its severity varies widely; some forms are mild and slowly progressive, while others are more serious and can progress to leukaemia.
How is MDS treated?
It ranges from monitoring and supportive care (such as transfusions) for milder disease, to medicines that improve counts or slow progression, and, for suitable people, a stem cell transplant that offers potential cure.
Sources
Where this is drawn from
- NHS — Myelodysplastic syndromes
- British Society for Haematology guidance
Related conditions
Browse by body system
Building a patient-information or formulary resource?
We create evidence-led, dose-free clinical references and decision aids for teams.